S62 TGFBeta Structure, Function, and Therapeutics

Program: Symposia
Basic/Translational Session
Sunday, April 3, 2016: 4:45 PM-6:15 PM
Room 157 (BCEC)
Alan Schneyer, PhD, University of Massachusetts Amherst and Fairbanks Pharmaceuticals, Springfield, MA

Nothing to Disclose: AS
4:45 PM
Thomas B Thompson, PhD, Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH
TBT: Consultant, Acceleron Pharma.
5:15 PM
Peter ten Dijke, PhD, Molecular Cell Biology, Leiden University Medical Center, Leiden, Netherlands
Nothing to Disclose: PT
5:45 PM
Craig Anthony Harrison, PhD, Growth Factor Signalling Laboratory, Hudson Institute of Medical Research, Clayton, VIC, Australia
Nothing to Disclose: CAH
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire